Our Services
Medical Information
Helpful Resources
Published on: 9/29/2026
Cyclobenzaprine 10 mg is a prescription muscle relaxant used short term to ease muscle spasms, pain, and stiffness caused by acute strains, sprains, or back and neck injuries, usually alongside rest and physical therapy. It is typically taken up to three times daily for only 2 to 3 weeks, because evidence of benefit beyond that window is limited and side effects like drowsiness, dry mouth, and dizziness can build. Dosing may differ for older adults, people with liver problems, or anyone taking antidepressants, tramadol, or sedatives, so several important factors apply to your situation. See the complete answer below for details on timing, tapering, interactions, and warning signs that mean you should call your prescriber.
If your spasms, pain, or stiffness are lingering past the expected few weeks, that may signal something other than a simple muscle strain, and guessing can delay the right care; a free, instant, online symptom check can help you organize your symptoms, understand likely causes, and decide whether to adjust treatment, see a clinician, or seek urgent attention.
Last reviewed for medical accuracy: 09/29/2026
What Is Cyclobenzaprine 10 mg Used For, and How Long to Take It
Cyclobenzaprine 10 mg is a prescription muscle relaxant often prescribed to ease painful muscle spasms. If you’re asking “what is cyclobenzaprine 10 mg used for,” you’ve come to the right place. This guide explains its uses, how it works, typical dosing, treatment length, safety considerations and next steps.
Cyclobenzaprine belongs to a class of medications called centrally acting skeletal muscle relaxants. It works on the central nervous system (brain and spinal cord) to reduce muscle spasms—sudden, involuntary contractions that can be painful and limit movement. Cyclobenzaprine 10 mg is most often used:
Key points about its use:
Because cyclobenzaprine can cause drowsiness and has a risk of dependence and tolerance, it is generally limited to short courses:
Why short-term?
Always follow your prescriber’s instructions. If pain or spasms persist beyond the intended course, revisit your healthcare provider to reassess treatment.
Cyclobenzaprine 10 mg is available as an oral tablet. Dosage may vary based on age, overall health and other medications. A common regimen:
Tips for safe dosing:
Most users tolerate cyclobenzaprine well for short periods. The most frequent side effects include:
Less common or serious effects may involve:
If you experience troubling symptoms, stop the medication and contact your healthcare provider. For any signs of breathing difficulty, chest pain or severe allergic reaction, seek emergency medical care immediately.
Before starting cyclobenzaprine 10 mg, discuss these factors with your doctor:
Use extra caution if you are older than 65 or have liver impairment, as you may be more sensitive to side effects.
While on cyclobenzaprine:
You and your doctor should consider discontinuation if:
To support your recovery:
If new or worsening symptoms arise, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Always report any life-threatening or serious issues—like severe chest pain or breathing trouble—to emergency services and then to your prescribing physician.
Before starting or stopping cyclobenzaprine 10 mg, or if you have any concerns, schedule an appointment. Speak to a doctor right away if you experience:
Your healthcare provider can confirm whether cyclobenzaprine is right for you, suggest alternative treatments and ensure safe use.
Cyclobenzaprine 10 mg can be a valuable short-term aid for acute muscle spasms when combined with rest, physical therapy and self-care measures. By understanding its uses, dosing limits and safety considerations, you can optimize relief and minimize risks. For any serious symptoms or life-threatening concerns, always speak to a doctor.
(References)
* Hucker HB, Stauffer SC, Albert KS, Lei BW. Plasma levels and bioavailability of cyclobenzaprine in human subjects. J Clin Pharmacol. 1977 Nov-Dec;17(11-12):719-27. doi: 10.1002/j.1552-4604.1977.tb01547.x. PMID: 925191.
* Ashby P, Burke D, Rao S, Jones RF. Assessment of cyclobenzaprine in the treatment of spasticity. J Neurol Neurosurg Psychiatry. 1972 Oct;35(5):599-605. doi: 10.1136/jnnp.35.5.599. PMID: 4563483; PMCID: PMC494138.
* Linden CH, Mitchiner JC, Lindzon RD, Rumack BH. Cyclobenzaprine overdosage. J Toxicol Clin Toxicol. 1983 May;20(3):281-8. doi: 10.3109/15563658308990071. PMID: 6620442.
* Friedman BW, Dym AA, Davitt M, Holden L, Solorzano C, Esses D, Bijur PE, Gallagher EJ. Naproxen With Cyclobenzaprine, Oxycodone/Acetaminophen, or Placebo for Treating Acute Low Back Pain: A Randomized Clinical Trial. JAMA. 2015 Oct 20;314(15):1572-80. doi: 10.1001/jama.2015.13043. PMID: 26501533.
* Li Y, Delcher C, Reisfield GM, Wei YJ, Brown JD, Winterstein AG. Utilization Patterns of Skeletal Muscle Relaxants Among Commercially Insured Adults in the United States from 2006 to 2018. Pain Med. 2021 Oct 8;22(10):2153-2161. doi: 10.1093/pm/pnab088. PMID: 33690860.
* Zhou J, Effiong U. Isolated Pyridoxine Deficiency Presenting as Muscle Spasms in a Patient With Type 2 Diabetes: A Case Report and Literature Review. Am J Med Sci. 2021 Jun;361(6):791-794. doi: 10.1016/j.amjms.2020.10.027. Epub 2020 Oct 31. PMID: 33958192.
* Akman TC. A Novel Method for Determination of Cyclobenzaprine in the Different Matrixes by UHPLC-DAD: Application to Real Human Plasma and Pharmaceutical Formulations. J Chromatogr Sci. 2024 Dec 11;62(10):953-961. doi: 10.1093/chromsci/bmad052. PMID: 37507110.
* Sublingual cyclobenzaprine (Tonmya) for fibromyalgia. Med Lett Drugs Ther. 2026 Jan 19;68(1746):9-10. doi: 10.58347/tml.2026.1746a. PMID: 41505652.
* St Onge E, Bui PT, Rogers H, Guerrero I, Phillips B. Cyclobenzaprine Reimagined: Clinical Insights Into Tonmya for Fibromyalgia. J Pharm Technol. 2026 Mar 10;42(3):87551225261426559. doi: 10.1177/87551225261426559. Epub 2026 Mar 10. PMID: 41822869; PMCID: PMC12975529.
* Cashin AG, Chou R, Weimer MB, McAuley JH. Low Back Pain: A Review. JAMA. 2026 Jul 14;336(2):144-158. doi: 10.1001/jama.2026.9631. PMID: 42295944.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.